Skip to main content
Erschienen in: Diabetologia 10/2012

01.10.2012 | Article

A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study

verfasst von: J. L. Vassy, N. H. Durant, E. K. Kabagambe, M. R. Carnethon, L. J. Rasmussen-Torvik, M. Fornage, C. E. Lewis, D. S. Siscovick, J. B. Meigs

Erschienen in: Diabetologia | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Genotype does not change over the life course and may thus facilitate earlier identification of individuals at high risk for type 2 diabetes. We hypothesised that a genotype score predicts incident type 2 diabetes from young adulthood and improves diabetes prediction models based on clinical risk factors alone.

Methods

The Coronary Artery Risk Development in Young Adults (CARDIA) study followed young adults (aged 18–30 years, mean age 25) serially into middle adulthood. We used Cox regression to build nested prediction models for incident type 2 diabetes based on clinical risk factors assessed in young adulthood (age, sex, race, parental history of diabetes, BMI, mean arterial pressure, fasting glucose, HDL-cholesterol and triacylglyercol), without and with a 38-variant genotype score. Models were compared with C statistics and continuous net reclassification improvement indices (NRI).

Results

Of 2,439 participants, 830 (34%) were black and 249 (10%) had a BMI ≥30 kg/m2 at baseline. Over a mean 23.9 years of follow-up, 215 (8.8%) participants developed type 2 diabetes. The genotype score significantly predicted incident diabetes in all models, with an HR of 1.08 per risk allele (95% CI 1.04, 1.13) in the full model. The addition of the score to the full model modestly improved reclassification (continuous NRI 0.285; 95% CI 0.126, 0.433) but not discrimination (C statistics 0.824 and 0.829 in full models with and without score). Race-stratified analyses were similar.

Conclusions/interpretation

Knowledge of genotype predicts type 2 diabetes over 25 years in white and black young adults but may not improve prediction over routine clinical measurements.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544PubMedCrossRef Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544PubMedCrossRef
2.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 346:393–403CrossRef Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 346:393–403CrossRef
3.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 344:1343–1350CrossRef Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 344:1343–1350CrossRef
4.
Zurück zum Zitat Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163 Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163
5.
Zurück zum Zitat Mainous AG, Diaz VA, Everett CJ (2007) Assessing risk for development of diabetes in young adults. Ann Fam Med 5:425–429PubMedCrossRef Mainous AG, Diaz VA, Everett CJ (2007) Assessing risk for development of diabetes in young adults. Ann Fam Med 5:425–429PubMedCrossRef
6.
Zurück zum Zitat Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763–768PubMedCrossRef Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763–768PubMedCrossRef
7.
Zurück zum Zitat Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060–1067PubMedCrossRef Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060–1067PubMedCrossRef
8.
Zurück zum Zitat Diabetes Genetics Initiative of Broad Institute of Harvard MIT Lund University and Novartis Institutes of BioMedical Research, Saxena R, Voight BF et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336PubMedCrossRef Diabetes Genetics Initiative of Broad Institute of Harvard MIT Lund University and Novartis Institutes of BioMedical Research, Saxena R, Voight BF et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336PubMedCrossRef
9.
Zurück zum Zitat Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef
10.
Zurück zum Zitat Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589PubMedCrossRef Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589PubMedCrossRef
11.
Zurück zum Zitat Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Eng J Med 359:2220–2232CrossRef Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Eng J Med 359:2220–2232CrossRef
12.
Zurück zum Zitat Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Eng J Med 359:2208–2219CrossRef Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Eng J Med 359:2208–2219CrossRef
13.
Zurück zum Zitat de Miguel-Yanes JM, Shrader P, Pencina MJ et al (2011) Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34:121–125PubMedCrossRef de Miguel-Yanes JM, Shrader P, Pencina MJ et al (2011) Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 34:121–125PubMedCrossRef
14.
Zurück zum Zitat Cutter GR, Burke GL, Dyer AR et al (1991) Cardiovascular risk factors in young adults: the CARDIA baseline monograph. Control Clin Trials 12:1S–77SPubMedCrossRef Cutter GR, Burke GL, Dyer AR et al (1991) Cardiovascular risk factors in young adults: the CARDIA baseline monograph. Control Clin Trials 12:1S–77SPubMedCrossRef
15.
Zurück zum Zitat Friedman GD, Cutter GR, Donahue RP et al (1988) CARIDA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41:1105–1116PubMedCrossRef Friedman GD, Cutter GR, Donahue RP et al (1988) CARIDA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 41:1105–1116PubMedCrossRef
16.
Zurück zum Zitat World Health Organization (1999) Part 1: Diagnosis and Classification of Diabetes Mellitus. In: World Health Organization Department of Noncommunicable Disease Surveillance (ed) Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland World Health Organization (1999) Part 1: Diagnosis and Classification of Diabetes Mellitus. In: World Health Organization Department of Noncommunicable Disease Surveillance (ed) Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland
17.
Zurück zum Zitat Bild DE, Jacobs DR Jr, Liu K et al (1996) Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol 6:235–245PubMedCrossRef Bild DE, Jacobs DR Jr, Liu K et al (1996) Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol 6:235–245PubMedCrossRef
18.
Zurück zum Zitat Hankinson AL, Daviglus ML, Bouchard C et al (2010) Maintaining a high physical activity level over 20 years and weight gain. JAMA 304:2603–2610PubMedCrossRef Hankinson AL, Daviglus ML, Bouchard C et al (2010) Maintaining a high physical activity level over 20 years and weight gain. JAMA 304:2603–2610PubMedCrossRef
19.
Zurück zum Zitat Lemaitre RN, Tanaka T, Tang W et al (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 7:e1002193PubMedCrossRef Lemaitre RN, Tanaka T, Tang W et al (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 7:e1002193PubMedCrossRef
20.
Zurück zum Zitat Lettre G, Palmer CD, Young T et al (2011) Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet 7:e1001300PubMedCrossRef Lettre G, Palmer CD, Young T et al (2011) Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet 7:e1001300PubMedCrossRef
21.
Zurück zum Zitat Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074PubMedCrossRef Wilson PWF, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074PubMedCrossRef
22.
Zurück zum Zitat Franks PW, Hanson RL, Knowler WC et al (2007) Childhood predictors of young-onset type 2 diabetes. Diabetes 56:2964–2972PubMedCrossRef Franks PW, Hanson RL, Knowler WC et al (2007) Childhood predictors of young-onset type 2 diabetes. Diabetes 56:2964–2972PubMedCrossRef
23.
Zurück zum Zitat Hosmer DW, Lemeshow S (1980) A goodness-of-fit test for the multiple logistic regression model. Comm Stat A10:1043–1069 Hosmer DW, Lemeshow S (1980) A goodness-of-fit test for the multiple logistic regression model. Comm Stat A10:1043–1069
24.
Zurück zum Zitat Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23:2109–2123PubMedCrossRef Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23:2109–2123PubMedCrossRef
25.
Zurück zum Zitat Pencina MJ, D’Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11–21PubMedCrossRef Pencina MJ, D’Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11–21PubMedCrossRef
26.
Zurück zum Zitat Pencina MJ, D’Agostino RB Sr, Demler OV (2012) Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 31:101–113PubMedCrossRef Pencina MJ, D’Agostino RB Sr, Demler OV (2012) Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 31:101–113PubMedCrossRef
27.
Zurück zum Zitat Hosmer DW, Lemeshow S (1995) Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med 14:2161–2172PubMedCrossRef Hosmer DW, Lemeshow S (1995) Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med 14:2161–2172PubMedCrossRef
28.
Zurück zum Zitat Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928–935PubMedCrossRef Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928–935PubMedCrossRef
29.
Zurück zum Zitat van Hoek M, Dehghan A, Witteman JC et al (2008) Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57:3122–3128PubMedCrossRef van Hoek M, Dehghan A, Witteman JC et al (2008) Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57:3122–3128PubMedCrossRef
30.
Zurück zum Zitat Talmud PJ, Hingorani AD, Cooper JA et al (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340:b4838PubMedCrossRef Talmud PJ, Hingorani AD, Cooper JA et al (2010) Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 340:b4838PubMedCrossRef
31.
Zurück zum Zitat Vaxillaire M, Veslot J, Dina C et al (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57:244–254PubMedCrossRef Vaxillaire M, Veslot J, Dina C et al (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57:244–254PubMedCrossRef
32.
Zurück zum Zitat Balkau B, Lange C, Fezeu L et al (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31:2056–2061PubMedCrossRef Balkau B, Lange C, Fezeu L et al (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31:2056–2061PubMedCrossRef
33.
Zurück zum Zitat Vassy JL, Mahapatra PD, Meigs JB, et al (2012) Genotype predicts type 2 diabetes in adulthood in a biracial adolescent population. In: American Heart Association Epidemiology and Prevention and Nutrition, Physical Activity and Metabolism 2012 Scientific Sessions, San Diego, CA Vassy JL, Mahapatra PD, Meigs JB, et al (2012) Genotype predicts type 2 diabetes in adulthood in a biracial adolescent population. In: American Heart Association Epidemiology and Prevention and Nutrition, Physical Activity and Metabolism 2012 Scientific Sessions, San Diego, CA
34.
Zurück zum Zitat Cooke JN, Ng MC, Palmer ND et al (2012) Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care 35:287–292PubMedCrossRef Cooke JN, Ng MC, Palmer ND et al (2012) Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care 35:287–292PubMedCrossRef
35.
Zurück zum Zitat Palmer ND, Hester JM, An SS et al (2011) Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 60:662–668PubMedCrossRef Palmer ND, Hester JM, An SS et al (2011) Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 60:662–668PubMedCrossRef
36.
Zurück zum Zitat Billings LK, Florez JC (2010) The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 1212:59–77PubMedCrossRef Billings LK, Florez JC (2010) The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 1212:59–77PubMedCrossRef
38.
Zurück zum Zitat Hivert MF, Jablonski KA, Perreault L et al (2011) An updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60:1340–1348PubMedCrossRef Hivert MF, Jablonski KA, Perreault L et al (2011) An updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60:1340–1348PubMedCrossRef
Metadaten
Titel
A genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study
verfasst von
J. L. Vassy
N. H. Durant
E. K. Kabagambe
M. R. Carnethon
L. J. Rasmussen-Torvik
M. Fornage
C. E. Lewis
D. S. Siscovick
J. B. Meigs
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2637-7

Weitere Artikel der Ausgabe 10/2012

Diabetologia 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.